Genome-Wide CRISPR Screening Identifies Genetic Modulators of Amyloid Precursor Protein Processing
Open Access
- 28 April 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (9) , 3926
Abstract
The proteolytic processing of the amyloid precursor protein (APP) is a core pathological event in Alzheimer’s disease (AD) pathogenesis, yet the global genetic regulatory networks modulating this process have not been fully characterized. To systematically identify novel regulators of APP cleavage, we performed a genome-wide CRISPR/Cas9 knockout screen utilizing an optimized UAS-GAL4-based cellular reporter, and identified genetic modulators governing amyloidogenic and non-amyloidogenic processing. The screen uncovered distinct functional gene clusters regulating the APP, prominently involving cellular metabolism, protein modification, and vesicular trafficking. Specifically, LDHB, PIAS2, CCDC53, and TRIM61 emerged as novel functional modulators. Biochemical validation confirmed that ablating these genes significantly alters the metabolic balance between sAPPα and amyloid-β (Aβ) production. Finally, integration with human AD transcriptomic datasets demonstrated that these identified modulators undergo significant dysregulation in clinics. Together, these findings establish a reporter-based functional screening framework for APP processing and identify candidate regulatory nodes linked to metabolism, protein modification, and vesicular trafficking. These candidates provide a resource for future mechanistic investigation and validation in more disease-relevant AD models.Keywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515110836)
- Higher Education Discipline Innovation Project (B16009)
- Construction Project of Liaoning Provincial Key Laboratory, China (2022JH13/10200026)
This publication has 47 references indexed in Scilit:
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Human iPSC 4R tauopathy model uncovers modifiers of tau propagationCell, 2024
- The hidden players: Shedding light on the significance of post-translational modifications and miRNAs in Alzheimer's disease developmentAgeing Research Reviews, 2023
- The β-Secretase BACE1 in Alzheimer’s DiseaseBiological Psychiatry, 2021
- Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse ModelsCell Reports, 2020
- Deciphering the neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPPα)Cellular and Molecular Life Sciences, 2020
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer LiabilitiesCell, 2015
- A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease MutationCell, 2015
- Sumoylation of amyloid precursor protein negatively regulates Aβ aggregate levelsBiochemical and Biophysical Research Communications, 2008
- Model‐guided microarray implicates the retromer complex in Alzheimer's diseaseAnnals of Neurology, 2005